T. Shepard

发表

Simultaneous determination of phenolphthalein and phenolphthalein glucuronide from dog serum, urine and bile by high-performance liquid chromatography.

L. Bailey, J. Wilhelm, T. Shepard, 1992, Journal of chromatography.

Estimation of area under the curve for drugs subject to enterohepatic cycling

L. Aarons, R. H. Reuning, T. Shepard, 1985, Journal of Pharmacokinetics and Biopharmaceutics.

I. Methods for digoxin and metabolite determination in urine, feces and plasma application to detection of Ṟ-dihydrodigoxin in humans and ; II. A theoretical examination of the kinetics of enterohepatic cycling /

T. Shepard, 1983 .

Influence of Dose Range on Degree of Nonlinearity Detected in Dose-Proportionality Studies for Drugs with Saturable Elimination: Single-Dose and Steady-State Studies

N. Lordi, T. Shepard, P. Sparrow, 1993, Pharmaceutical Research.

Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.

L. Aarons, R. H. Reuning, T. Shepard, 1985, Journal of Pharmacy and Science.

Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaks.

G. Houin, I. Carrié, P. Hermann, 1998, Arzneimittel-Forschung.

Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.

G. Lockwood, D. Gannaway, T. Shepard, 1985, Journal of pharmaceutical sciences.

Mean residence time for drugs subject to enterohepatic cycling

L. Aarons, I. Abrahams, G. Lockwood, 1989, Journal of Pharmacokinetics and Biopharmaceutics.

An Equation for the Systemic Availability of Drugs Undergoing Simultaneous Enterohepatic Cycling, First-Pass Metabolism, and Intestinal Elimination

R. H. Reuning, T. Shepard, 1987, Pharmaceutical Research.

Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique.

R. Sams, J. Caldwell, L. Robertson, 1986, Journal of chromatography.